Cellumen And Alzheimer’s Drug Discovery Foundation Announce New Novel Alzheimer’s Screening Tool

Cellumen announced the commercial availability of a novel pharmaceutical screening technology to help discover new drugs to treat Alzheimer’s disease. This technology was jointly developed by Cellumen and the Alzheimer’s Drug Discovery Foundation (ADDF).

More: continued here

Filed under: Alzheimer's / Dementia News XML/RSS Feed on April 6th, 2009